Cantitate/Preț
Produs
Total produse
Vezi coșul
Handbook of Biological Therapeutic Proteins: Regulatory, Manufacturing, Testing, and Patent Issues de Sarfaraz Niazi

Handbook of Biological Therapeutic Proteins: Regulatory, Manufacturing, Testing, and Patent Issues

Autor Sarfaraz Niazi
en Limba Engleză Hardback – 15 apr 2024
Since 1972, which marks the invention of recombinant engineering, more than 500 therapeutic proteins have been approved for clinical use. Today, biological drugs constitute almost 70% of all new drugs and have a biological origin. The first edition of this book dealt with biosimilars, and this edition (i.e., the second edition) focuses on new drugs, yet limits to therapeutic proteins. Newer technologies for drug development represent the updated topics in the book and include repur-posing, AI- driven identification of newer designs, novel expression systems, manufacturing using these systems, rapidly changing regulatory pathways, and legal hurdles. This edition discusses how to identify, develop, manufacture, and take multibillion dollar products to market within the shortest possible time.
Features:
  • Complete and thorough coverage of the regulatory and technological challenges of developing generic therapeutic proteins
  • Comprehensive, discovery to market, newer technologies, regulatory planning and IP hurdles are included that are not found elsewhere
  • Expanded volume that must be in the hands of every company interested in biological drugs, including the mRNA-based biopharmaceutical companies fast appearing on the market
  • Discusses how to identify, develop, manufacture, and take multibillion dollar products to market in the shortest possible time
  • Renowned author and entrepreneur in the field of drug discovery and production
Citește tot Restrânge

Preț: 87886 lei

Preț vechi: 118300 lei
-26% Nou

Puncte Express: 1318
Preț estimativ în valută:
16818€ • 17734$ • 14001£

Carte tipărită la comandă

Livrare economică 11-25 ianuarie 25

 Adaugă în coș

Wish list
Gift list
Am citit!
Adaugă în listă
Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9781032489605
ISBN-10: 103248960X
Pagini: 412
Ilustrații: 69 Tables, black and white; 35 Line drawings, color; 17 Line drawings, black and white; 4 Halftones, color; 1 Halftones, black and white; 39 Illustrations, color; 18 Illustrations, black and white
Dimensiuni: 178 x 254 mm
Greutate: 0.92 kg
Ediția:2 ed
Editura: CRC Press
Colecția CRC Press

Public țintă

Academic and Professional Practice & Development

Cuprins

Chapter 1 Biosimilar Biopharmaceuticals
Chapter 2 Regulatory Requirements
Chapter 3 Development Master Plan
Chapter 4 Trends in Recombinant Proteins Manufacturing
Chapter 5 Analytical Assessment
Chapter 6 Clinical Pharmacology Assessment
Chapter 7 Clinical Immunogenicity Assessment
Chapter 8 Clinical Efficacy Assessment
Chapter 9 Recombinant Manufacturing System
Chapter 10 Upstream Processing
Chapter 11 Downstream Process
Chapter 12 Formulation of Biopharmaceuticals
Chapter 13 Quality and Compliance Systems
Chapter 14 Intellectual Property Issues for Scientists
Chapter 15 Advances in Biomanufacturing

Notă biografică

Sarfaraz K Niazi, Ph.D., is an Adjunct Professor at the University of Illinois. He has authored 60+ major books, 100+ research papers, and 100+ patents, mainly in bioprocessing. He has hands-on experience establishing biopharmaceutical projects, from concept to market, including setting up the first biosimilar company in the US and leading to several FDA approvals. He serves as an advisor to several regulatory agencies, including the FDA.

Descriere

Since 1972 when recombinant engineering was invented, over 500 therapeutic proteins have been approved. Today, biological drugs constitute almost 70% of all new drugs and are of biological origin. The first edition of this book dealt with biosimilars, the second focuses on new drugs yet limits to therapeutic proteins.